Jaguar Health, Inc. (JAGX) IPO - S-1 Filing, Stock & Insider Activity
Jaguar Health, Inc. IPO - Status & S-1 Filing
- Ticker: JAGX
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-07-16
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 41,000,000
- SEC CIK: 0001585608 · View the S-1 on SEC EDGAR →
Jaguar Health, Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Jaguar Health, Inc. (JAGX) - no SEC Form 4 insider filings recorded in the last 90 days. 14 Form 8-K material event filings were reported by JAGX in the last 90 days. InsiderAlpha tracks every JAGX SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. trades under the ticker JAGX. InsiderAlpha tracks 20 primary SEC Form 4 filings from 9 reporting insiders for JAGX since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001585608 |
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 14 |
|---|---|
| Latest Form 4 filing | 2026-03-12 |
Recent JAGX Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John Micek | Insider | A - Grant or award | 7.4K | $0.00 | - | SEC | |
| Steven R. King | Insider | A - Grant or award | 11.7K | $0.00 | - | SEC | |
| Lisa A. Conte | Chief Exec. Officer & President | A - Grant or award | 28.6K | $0.00 | - | SEC | |
| Jonathan S. Wolin | Chief of Staff, Chief Compliance Officer & General Counsel | A - Grant or award | 11.7K | $0.00 | - | SEC | |
| Lisa A. Conte | CEO and President | M - Option exercise | 2 | - | - | SEC | |
| Jonathan S. Wolin | Insider | A - Grant or award | 4.9K | $0.00 | - | SEC | |
| Carol R. Lizak | Chief Financial Officer | A - Grant or award | 4.3K | $0.00 | - | SEC | |
| Steven R. King | Insider | A - Grant or award | 4.9K | $0.00 | - | SEC | |
| Lisa A. Conte | Insider | A - Grant or award | 16.5K | $0.00 | - | SEC | |
| Pravin R. Chaturvedi | Chief Scientific Officer | A - Grant or award | 4.9K | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Jaguar Health, Inc. (JAGX). Updated in real time as new filings are submitted to the SEC.
Recent JAGX Form 8-K Material Events
- - Item 1.01, 9.01 [SEC]
- - Item 8.01 [SEC]
- - Item 1.01, 8.01, 9.01 [SEC]
- - Item 7.01, 9.01 [SEC]
- - Item 7.01, 9.01 [SEC]
Recent Insider Filings
- - John Micek (Insider)
- - Steven R. King (Insider)
- - Lisa A. Conte (Chief Exec. Officer & President)
- - Jonathan S. Wolin (Chief of Staff, Chief Compliance Officer & General Counsel)
- - Lisa A. Conte (CEO and President)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in JAGX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
JAGX Insider Trading - FAQ
- What is the latest insider trade for JAGX?
- Jaguar Health, Inc. (JAGX) had 0 insider filings in the last 90 days, with the most recent on 2026-03-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying JAGX stock?
- 0 insider purchases of JAGX were filed in the last 90 days.
- How many insiders are selling JAGX stock?
- 0 insider sales of JAGX were filed in the last 90 days.
- Where can I see JAGX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks JAGX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $JBIO Jade Biosciences, Inc.
- $JUNS JUPITER NEUROSCIENCES, INC.
- $KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
- $KOD Kodiak Sciences Inc.
- $KRRO Korro Bio, Inc.
- $KYMR Kymera Therapeutics, Inc.
- $LAB STANDARD BIOTOOLS INC.
- $LBRX LB PHARMACEUTICALS INC
- $LEXX Lexaria Bioscience Corp.
- $LGVN Longeveron Inc.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live JAGX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.